ASX:EMDEmerald Clinics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Emerald Clinics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.06 0.00 (0.00 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.06Now: A$0.06▼A$0.0650-Day RangeA$0.06MA: A$0.07▼A$0.0852-Week RangeA$0.04Now: A$0.06▼A$0.16Volume471,333 shsAverage VolumeN/AMarket Capitalization$11.03 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Emerald Clinics Limited operates a network of patient-centered medical clinics that offer cannabinoid-based treatment services. It operates four medical centers in Australia. The company was incorporated in 2018 and is based in North Perth, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Emerald Clinics. Previous Next 3.0 Community Rank Outperform VotesEmerald Clinics has received 3 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEmerald Clinics has received 2 “underperform” votes. (Add your “underperform” vote.)Community SentimentEmerald Clinics has received 60.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Emerald Clinics and other stocks. Vote “Outperform” if you believe EMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EMD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEmerald Clinics does not currently pay a dividend.Dividend GrowthEmerald Clinics does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Emerald Clinics insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$6,100.00 in company stock and sold A$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Emerald Clinics is -2.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Emerald Clinics is -2.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.20 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolASX:EMD Previous Symbol CUSIPN/A CIKN/A Webwww.emeraldclinics.com.au Phone61 8 6559 2800Debt Debt-to-Equity RatioN/A Current Ratio1.64 Quick Ratio1.43Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$540,576.00 Price / Sales20.41 Cash FlowA$0.01 per share Price / Cash Flow6.67 Book ValueA($0.01) per share Price / Book-5.45Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares183,903,008Market Cap$11.03 million Next Earnings DateN/A OptionableNot Optionable Receive EMD News and Ratings via Email Sign-up to receive the latest news and ratings for EMD and its competitors with MarketBeat's FREE daily newsletter. Emerald Clinics (ASX:EMD) Frequently Asked Questions Has Emerald Clinics been receiving favorable news coverage? News coverage about EMD stock has trended somewhat negative recently, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Emerald Clinics earned a news impact score of -1.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the next few days. View the latest news aboutEmerald Clinics. Who are some of Emerald Clinics' key competitors? Some companies that are related to Emerald Clinics include Reliq Health Technologies (RHT), Novita Healthcare (NHL), Vitalhub (VHI), Induction Healthcare Group (INHC), Oneview Healthcare (ONE), 1ST Group (1ST), Diagnos (ADK), ICSGlobal (ICS), Jayex Healthcare (JHL), Global Health (GLH), CardioComm Solutions (EKG), CannaOne Technologies (CNONF), CannaOne Technologies (CNNA), Corum Group (COO) and eWELLNESS HEALTHCARE (EWLL). View all competitors. Who are Emerald Clinics' key executives? Emerald Clinics' management team includes the following people: Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D., Exec. Chairman (Age 50)Dr. Michael Winlo, MD & DirectorMs. Su-Mei Sain, Chief Financial OfficerMr. Adam James, Chief Operating OfficerDr. Alistair Vickery, Exec. Director What is Emerald Clinics' stock symbol? Emerald Clinics trades on the ASX under the ticker symbol "EMD." What is Emerald Clinics' stock price today? One share of EMD stock can currently be purchased for approximately A$0.06. How big of a company is Emerald Clinics? Emerald Clinics has a market capitalization of $11.03 million and generates $540,576.00 in revenue each year. What is Emerald Clinics' official website? The official website for Emerald Clinics is www.emeraldclinics.com.au. How can I contact Emerald Clinics? The company can be reached via phone at 61 8 6559 2800. This page was last updated on 5/30/2020 by MarketBeat.com Staff
